GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genpharmasec Ltd (BOM:531592) » Definitions » Cash per Share

Genpharmasec (BOM:531592) Cash per Share : ₹0.00 (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Genpharmasec Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Genpharmasec's Cash per Share for the quarter that ended in Dec. 2024 was ₹0.00.


Genpharmasec Cash per Share Historical Data

The historical data trend for Genpharmasec's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpharmasec Cash per Share Chart

Genpharmasec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.24 0.09 0.06 0.37

Genpharmasec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.37 - 0.07 -

Genpharmasec Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Genpharmasec's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Genpharmasec's Cash per Share for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genpharmasec  (BOM:531592) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Genpharmasec Cash per Share Related Terms

Thank you for viewing the detailed overview of Genpharmasec's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Genpharmasec Business Description

Traded in Other Exchanges
N/A
Address
Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101
Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in two reportable segments namely; Diagnostic Pharma Equipment which includes pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, and herbs, and pharmaceutical, medicinal, and proprietary and industrial preparations, compounds, and articles of kinds, chemists, druggists, and chemical manufacturers. The Trading in the Securities segment of the company invests in the secondary securities market. The Diagnostic Pharma Equipment segment is the key revenue generator for the group.

Genpharmasec Headlines

No Headlines